The autonomic symptom profile a new instrument to assess autonomic symptoms

Neurology

Volumn 52, Issue 3, 1999, Pages 523-528

  Suarez, Guillermo A ^a   Opfer Gehrking, T L ^a   Offord, K P ^a   Atkinson, E J ^a   O'Brien, P C ^a   Low, P A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RELIABILITY; SCORING SYSTEM; SELF REPORT; SYMPTOM;

EID: 0033016944     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.3.523     Document Type: Article

References (15)

1. Dyck PJ, Karnes J, O'Brien PC, Swanson CJ. Neuropathy Symptom Profile in health, motor neuron disease, diabetic neuropathy, and amyloidosis. Neurology 1986;36:1300-1308.
2. Low PA, Opfer-Gehrking TL, McPhee BR, et al. Prospective evaluation of clinical characteristics of orthostatic hypotension. Mayo Clin Proc 1995;70:617-622.
3. Low PA. Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure. Mayo Clin Proc 1993;68:748-752.
4. Low PA. Laboratory evaluation of autonomic function. In: Low PA, ed. Clinical autonomic disorders: evaluation and management. 2nd ed. Philadelphia: Lippincott-Raven, 1997:179-208.
5. Low PA, Pfeifer MA. Standardization of autonomic function. In: Low PA, ed. Clinical autonomic disorders: evaluation and management. 2nd ed. Philadelphia: Lippincott-Raven, 1997: 287-295.
6. O'Gorman TW, Woolson RF. Using Kendall's tau b correlations to improve variable selection methods in case-control studies. Biometrics 1995;51:1451-1460.
7. Suarez GA, Fealey RD, Camilleri M, Low PA. Idiopathic autonomic neuropathy: clinical, neurophysiologic, and follow-up studies on 27 patients. Neurology 1994;44:1675-1682.
8. Ewing DJ, Campbell IW, Clarke BF. The natural history of diabetic autonomic neuropathy. Q J Med 1980;49:95-108.
9. Fernandez-Castaner M, Mendola G, Levy I, Gomis R, Figuerola D. Prevalence and clinical aspects of cardiovascular vegetative neuropathy in a diabetic population. Med Clin (Bare) 1985;84:215-218.
10. Ewing DJ, Campbell IW, Clarke BF. Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications. Ann Intern Med 1980;92:308-311.
11. Chambers JB, Sampson MJ, Sprigings DC, Jackson G. QT prolongation on the electrocardiogram in diabetic autonomic neuropathy [see comments]. Diabet Med 1990;7:105-110.
12. Burgos LG, Ebert TJ, Asiddao C, et al. Increased intraoperative cardiovascular morbidity in diabetics with autonomic neuropathy. Anesthesiology 1989;70:591-597.
13. Knuttgen D, Weidemann D, Doehn M. Diabetic autonomic neuropathy: abnormal cardiovascular reactions under general anesthesia. Klin Wochenschr 1990;68:1168-1172.
14. Fagius J, Brattberg A, Jameson S, Berne C. Limited benefit of treatment of diabetic polyneuropathy with an aldose reductase inhibitor: a 24-week controlled trial. Diabetologia 1985; 28:323-329.
15. McEvoy KM, Windebank AJ, Daube JR, Low PA. 3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome. N Engl J Med 1989;321:1567-1571.